Searched for
SWEDEN STUDY AI CANCER
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...- 'The Donald of Dubai': UAE billionaire close to Trump bets $66 billion on AI to become the world's data kingUAE real estate magnate Hussain Sajwani is investing billions in data centers to capitalize on the AI boom, aiming for global leadership. H...
- Anthropic unveils Claude Fable 5, making a shift toward autonomous AI agentsAnthropic has launched Claude Fable 5 and Claude Mythos 5, introducing a new class of AI models designed for long-horizon, autonomous tasks...
- India can take the lead in applying AI in industries: SAP CEO Christian KleinSAP CEO Christian Klein believes India can lead in applying AI to industries like manufacturing and finance, rather than just replicating l...
- AI saves clinicians time but most lack training, survey findsArtificial intelligence is helping doctors and nurses save time and see more patients. However, a Philips survey shows most healthcare work...
- US stocks: US market rises as tech shares gain, Middle East tensions easeWall Street indexes opened higher on Tuesday, driven by a second consecutive day of gains for chipmakers. Easing Middle East tensions also ...
- From chatbots to behavioural AI: Stanford study reveals emerging AI personality systemsAI is increasingly simulating stable human-like behaviour, often perceived as personality. Stanford HAI research shows these patterns arise...
- SpaceX IPO: How to buy shares in Elon Musk company? Full list of countries from which international investors can buy stocksHow to buy SpaceX IPO: Trading under the symbol SPCX, SpaceX has picked a handful of brokerage firms to distribute shares in the IPO to ret...
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
- Elon Musk Net Worth: From $788,800,000,000 today to a possible $1,000,000,000,000 after SpaceX IPO— How much would each of his 14 children get?Elon Musk Net Worth June 2026: According to Forbes, Elon Musk’s fortune stood at approximately $788.8 billion on June 8, 2026. Some project...
- Weekly Horoscope for ♋ CANCER (June 8 - June 14, 2026): What Unexpected Blessings and Opportunities Are Coming Your Way?Cancer Weekly Horoscope (June 8 - June 14, 2026): This weekly horoscope indicates a progressive week for Cancer natives. The Moon starts th...
- This blood test may reveal lung cancer risk long before symptomsA new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....
- Can’t find a job after graduation? Blame WFH, not AIRecent graduates are blaming AI for a tough job market, but new studies suggest remote work is the primary culprit. WFH policies make it ha...
- India joins elite heavy-haul railway club, targets lower logistical costs: DFCCIL MDIndia now operates heavy-haul freight railways, joining a select global group. The nation is adopting advanced technologies and global best...
- India leads global AI adoption at work: BCG reportIndia leads the world in using AI at work. Employees and managers are adopting AI tools widely. This adoption boosts job satisfaction signi...
- New Workforce Study Finds AI Capabilities Reaching More Occupations Earlier Than AnticipatedA new study suggests artificial intelligence is reshaping the workforce faster than previously expected, with 93% of occupations now consid...
- Anthropic expanding Mythos AI model access to India: ReportAnthropic had announced on Tuesday that it gave approximately 150 organisations around the world access to its AI model Mythos, whose abili...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Load More
